|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Iterum Therapeutics (NASDAQ: ITRM) through any online brokerage.
The latest price target for Iterum Therapeutics (NASDAQ: ITRM) was reported by SVB Leerink on 2020-10-01. The analyst firm set a price target for 1.50 expecting ITRM to fall to within 12 months (a possible -0.66% downside). 4 analyst firms have reported ratings in the last year.
The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.51 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Iterum Therapeutics.
There is no upcoming split for Iterum Therapeutics.